Effects of Nerve Blocks on Pain After Caesarean Section and Postpartum Depression
Effects of Transversus Abdominis and Erector Spina Plane Blocks on Post-Cesarean Pain Control and Postpartum Depression
1 other identifier
interventional
60
1 country
1
Brief Summary
At the end of your cesarean section surgery, which is started by applying medication to the spinal cavity from your waist, pain medication will be applied between the relevant muscle and its covering from your lower abdomen or back with the help of ultrasonography and a special block needle. Then, a patient-controlled pain device with a serum containing painkillers will be connected to your vascular access, and its use and purpose will be explained to you. You will be asked about your pain condition and the severity score of your pain, if any, at certain hourly intervals. At the end of 24 hours, a pain device will be removed, your satisfaction will be questioned and your complaints, if any, will be recorded. Immediately before surgery and 4-6 days after your surgery. An evaluation survey consisting of 10 questions will be asked to you within a 5-minute period during the weeks, at a time when you are free, and your answers will be recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 15, 2024
CompletedFirst Posted
Study publicly available on registry
January 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedSeptember 19, 2024
July 1, 2024
Same day
January 15, 2024
September 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain (VAS score)
Evaluation of the postoperative analgesic effectiveness of erector spinae and transversus abdominis plane blocks after cesarean section
12 months
Secondary Outcomes (1)
Postpartum depression (Edinnburg Depression Scale)
12 months
Study Arms (2)
Group E
ACTIVE COMPARATORPatients who underwent erector spinae plane block
Group T
ACTIVE COMPARATORPatients who underwent transversus abdominis plane block
Interventions
Group E: While performing the erector spina plan block; Patients are placed in the lateral decubitus position, aseptic conditions are provided, the spinous process in the midline is determined under ultrasonography guidance, and the transverse process is determined 3 cm laterally from the T11 level. 100 mm 22G block needle erector. Group T: The lumbar petit region will be determined and placed on the lateral abdominal wall at the mid-axillary line, between the iliac crest and the lower costal arch, via a linear probe (12-15 MHz probe). After determining the internal oblique muscle as the thickest muscle and the transversus abdominis muscle as the thinnest muscle, a 100 mm 22 G needle will be placed in the same plane as the USG probe (in-plane or long axis technique). The progress of the needle will be observed on ultrasound along with the facial click sensation. After the second click sensation is felt between the internal oblique and transversalis fascia.
Eligibility Criteria
You may qualify if:
- Having a good mental status,
- Those aged ≥18 years,
- Term pregnant (gestational age ≥ 36 weeks),
- American Society of Anesthesiologists class II-III,
- Patients who underwent cesarean section with spinal anesthesia will be included.
You may not qualify if:
- Having labor at term or obstetric emergency,
- Having a twin pregnancy,
- Having a diagnosed psychiatric disorder/using psychiatric medication,
- Those who are allergic to local anesthetics and/or drugs used in the study,
- The patient-controlled anesthesia device is out of use for any reason within the first 24 hours postoperatively,
- Having peripheral neuropathy or neuromuscular disease,
- Patients using anticoagulant drugs that will prevent regional anesthesia will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
KahramanmarasSIU
Kahramanmaraş, Kahramanmaraş, 46100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
January 15, 2024
First Posted
January 24, 2024
Study Start
November 1, 2023
Primary Completion
November 1, 2023
Study Completion
October 1, 2024
Last Updated
September 19, 2024
Record last verified: 2024-07